Benzydamine: A Pharmaceutical Overview of Benzydamine Hydrochloride
Benzydamine is a pharmaceutical active ingredient used in topical and oromucosal preparations. In pharmaceutical formulations, it is commonly used in the form of Benzydamine Hydrochloride, also written as Benzydamine HCl.
Benzydamine-based preparations are available in dosage forms designed for localized application, including mouthwash, oromucosal spray and cream.
For pharmaceutical companies developing Benzydamine products, understanding the active pharmaceutical ingredient, pharmacopeial quality parameters, formulation characteristics and finished-product testing requirements is important for developing a consistent pharmaceutical product.
Sharing Formulations Pvt. Ltd. specializes in pharmaceutical liquid external preparations, with particular experience in Benzydamine Mouthwash and related oromucosal formulations.
What Is Benzydamine?
Benzydamine is an active pharmaceutical ingredient belonging to the analgesic and anti-inflammatory category.
The hydrochloride salt, Benzydamine Hydrochloride, is used for the manufacture of pharmaceutical preparations intended for localized application.
Unlike the finished pharmaceutical product, Benzydamine HCl itself is supplied as an API that must comply with appropriate quality specifications before being introduced into the manufacturing process.
What Is Benzydamine Hydrochloride?
Benzydamine Hydrochloride, commonly abbreviated as Benzydamine HCl, is the hydrochloride salt form of Benzydamine.
According to the pharmaceutical specification referenced by Sharing Formulations, Benzydamine HCl is described as:
A white or almost white crystalline powder.
When used for pharmaceutical manufacturing, the API is evaluated through identity testing, impurity testing, residual-solvent testing and other specified quality-control parameters.
These controls help establish whether the raw material meets the required pharmaceutical quality standard before use in production.
Benzydamine vs Benzydamine Hydrochloride
The terms Benzydamine and Benzydamine Hydrochloride are closely related but technically not identical.
Benzydamine refers to the active molecule, while Benzydamine Hydrochloride refers to its hydrochloride salt form used in pharmaceutical preparations.
For this reason, pharmaceutical product labels and specifications may commonly describe the ingredient as:
Benzydamine Hydrochloride
or
Benzydamine HCl
When searching technical literature, product information or pharmaceutical manufacturing information, all three terms may therefore appear:
- Benzydamine
- Benzydamine Hydrochloride
- Benzydamine HCl
Pharmaceutical Category of Benzydamine
Benzydamine is categorized as an active ingredient with analgesic and anti-inflammatory properties.
Because Benzydamine can be formulated into preparations intended for localized use, it is particularly relevant to pharmaceutical dosage forms intended for application within the oral cavity, oropharyngeal area or on appropriate topical sites.
The characteristics of the final product depend not only on the active ingredient but also on the dosage form, vehicle, concentration, excipient system and manufacturing process.
Benzydamine Dosage Forms
The supplied BP-related pharmaceutical information identifies several dosage forms for Benzydamine.
1. Benzydamine Mouthwash
Benzydamine Mouthwash consists of Benzydamine Hydrochloride incorporated into a suitable pharmaceutical vehicle.
The vehicle may also contain appropriately selected flavouring, colouring and other formulation ingredients according to the approved formulation.
Benzydamine Mouthwash is an important pharmaceutical dosage form because it enables the active ingredient to be presented as a liquid preparation for localized application within the oral cavity.
2. Benzydamine Oromucosal Spray
Benzydamine can also be formulated as an oromucosal spray.
Spray formulations require careful consideration of formulation characteristics as well as the delivery system.
Important development considerations may include:
- Product concentration
- Solution characteristics
- pH
- Pump compatibility
- Spray delivery
- Packaging compatibility
- Finished-product assay
- Stability
3. Benzydamine Cream
Benzydamine Hydrochloride may also be formulated into a suitable cream base.
The physical characteristics and analytical requirements of a semi-solid product differ from those of a mouthwash or spray, making dosage-form-specific formulation development important.
Benzydamine HCl Quality Parameters
Pharmaceutical-grade Benzydamine Hydrochloride should be evaluated against defined specifications.
The supplied Benzydamine HCl BP information includes testing related to several important quality parameters.
Identification
Identity testing is performed to confirm that the raw material is Benzydamine Hydrochloride.
The referenced specification includes:
- Identification by IR
- Positive reaction for chlorides
Identity testing forms an essential part of API release before pharmaceutical manufacturing.
Related Substances in Benzydamine HCl
Control of related substances is important in pharmaceutical API quality assessment.
The supplied specification includes defined limits for several related substances associated with Benzydamine Hydrochloride.
These include specified impurities as well as:
Unspecified impurities: NMT 0.10%
and
Total impurities: NMT 1.0%
Monitoring related substances helps maintain consistency and quality of the active pharmaceutical ingredient.
Benzydamine API Impurity Control
The supplied specification also identifies an impurity associated with:
3-chloro-N, N-dimethylpropan-1-amine
with a specified limit of:
NMT 5 ppm
and testing by gas chromatography.
Such testing demonstrates the importance of controlling trace impurities in pharmaceutical-grade active ingredients.
Residual Solvents in Benzydamine Hydrochloride
Residual solvents may remain from API manufacturing processes and therefore require appropriate control.
The referenced Benzydamine HCl specification identifies testing by gas chromatography for several solvents, including:
- Methanol
- Isopropanol
- Toluene
- Chlorobenzene
- Dimethyl sulphoxide
Defined acceptance limits are provided for each solvent in the specification.
For pharmaceutical manufacturers, raw-material qualification therefore involves much more than simply confirming the assay of the active ingredient.
A complete API quality assessment may require evaluation of identity, related substances, residual solvents and other physicochemical parameters.
Loss on Drying and Sulphated Ash
Additional quality parameters specified for Benzydamine Hydrochloride include:
Loss on drying: NMT 1.0%
and
Sulphated ash: NMT 0.1%
These tests form part of the overall pharmaceutical quality specification for the API.
Benzydamine Mouthwash Quality Testing
Once Benzydamine Hydrochloride has been converted into a mouthwash, quality testing shifts from API-specific parameters to finished-product specifications.
The supplied pharmaceutical specification identifies several tests relevant to Benzydamine Mouthwash and Oromucosal Spray.
These include:
- Identification
- pH
- Testing for specified related material
- Assay
Finished-product testing is important because pharmaceutical quality must be demonstrated in the actual marketed dosage form and not only in the original API.
pH of Benzydamine Mouthwash
According to the referenced specification, the stated acidity or alkalinity range for Benzydamine Mouthwash is:
pH 5.0 to 7.0
pH is an important pharmaceutical formulation parameter because it can influence the behaviour of active and inactive ingredients within a liquid preparation.
Maintaining the desired pH therefore requires appropriate control during formulation, manufacturing and stability evaluation.
Assay of Benzydamine Mouthwash
Assay testing determines the amount of Benzydamine present in the finished pharmaceutical product.
The referenced specification identifies gas chromatography for assay-related testing of the mouthwash.
Assay control helps establish whether the finished formulation contains the intended amount of active ingredient within its approved specification.
Why Benzydamine Formulation Development Matters
Manufacturing a stable pharmaceutical liquid involves more than dissolving an API in water.
A Benzydamine formulation contains several components that must remain compatible throughout the intended shelf life.
Depending on the formulation, development may involve evaluation of:
- Benzydamine HCl solubility
- pH
- Purified water quality
- Flavouring system
- Sweetening system
- Colour
- Preservative system
- Solubilization
- Packaging material
- Closure system
- Pump compatibility for sprays
- Finished-product assay
- Related substances
- Microbial quality
- Stability
A formulation that appears satisfactory immediately after manufacture must also demonstrate acceptable characteristics during storage.
For this reason, formulation development and stability evaluation are important elements of pharmaceutical product development.
Benzydamine Mouthwash 0.15% w/v
One commonly used pharmaceutical presentation is:
Benzydamine Hydrochloride 0.15% w/v Mouthwash
Sharing Formulations Pvt. Ltd. has developed specialized experience in the manufacturing of Benzydamine Mouthwash as part of its pharmaceutical liquid external preparation portfolio.
Our focus includes commercial-scale manufacturing of mouthwash preparations for pharmaceutical companies under appropriate manufacturing arrangements.
Alcohol-Free Benzydamine Mouthwash
Benzydamine Mouthwash can also be developed using an alcohol-free formulation approach.
Removing alcohol from a liquid formulation requires careful selection of the pharmaceutical vehicle and other formulation components.
Particular attention may need to be given to:
- Solubilization
- Flavour system
- Product clarity
- Ingredient compatibility
- Preservation
- pH
- Stability
Sharing Formulations has experience with alcohol-free Benzydamine Mouthwash formulations intended for B2B pharmaceutical manufacturing.
Role of Purified Water in Benzydamine Mouthwash
Water is one of the major components of many pharmaceutical mouthwash formulations.
The quality of water used in pharmaceutical manufacturing can therefore affect the consistency and microbiological quality of the finished preparation.
A pharmaceutical manufacturing facility must appropriately control the generation, storage and distribution of purified water used in formulation manufacturing.
This is particularly important for aqueous mouthwash products.
Benzydamine Manufacturing Expertise at Sharing Formulations
Sharing Formulations Pvt. Ltd. is a pharmaceutical manufacturer focused on liquid external preparations.
Our manufacturing portfolio includes pharmaceutical mouthwashes, gargles, antiseptic solutions and related oral topical preparations.
Benzydamine is an important area of formulation expertise within our mouthwash portfolio.
Our B2B manufacturing services are intended for pharmaceutical organizations seeking:
- Benzydamine Mouthwash manufacturing
- Benzydamine HCl Mouthwash
- Alcohol-free Benzydamine Mouthwash
- Private-label manufacturing
- White-label manufacturing
- Third-party manufacturing
- Contract manufacturing
- Loan licence manufacturing, where applicable
- Commercial-scale mouthwash production
Mucofresh – Benzydamine HCl Mouthwash
Mucofresh represents Sharing Formulations' experience in the Benzydamine Mouthwash category.
The product platform is based on Benzydamine Hydrochloride 0.15% w/v Mouthwash and reflects our specialization in pharmaceutical mouthwash formulation and manufacturing.
Multiple commercial pack-size configurations can be considered depending on market and customer requirements.
Benzydamine Mouthwash Pack Sizes
Sharing Formulations can support multiple pack sizes for Benzydamine Mouthwash, including:
35 mL, 50 mL, 100 mL, 150 mL, 200 mL, 250 mL, 300 mL, 500 mL and 1000 mL.
Packaging selection should consider the intended market, dosing requirements, bottle compatibility, closure system and applicable regulatory requirements.
Benzydamine HCl Manufacturing Partner in India
Pharmaceutical marketing companies looking to introduce a Benzydamine Mouthwash product may work with an experienced contract manufacturer instead of establishing a dedicated mouthwash manufacturing facility.
Sharing Formulations Pvt. Ltd. provides B2B manufacturing support for companies looking for pharmaceutical liquid external preparations.
Our approach emphasizes:
Formulation expertise + pharmaceutical manufacturing + quality control + commercial scalability
This allows our customers to concentrate on their pharmaceutical marketing and distribution activities while manufacturing is handled through an established formulation facility.
Conclusion
Benzydamine Hydrochloride is an important pharmaceutical active ingredient used in dosage forms including mouthwash and oromucosal spray.
Producing a pharmaceutical-quality Benzydamine preparation requires appropriate API qualification, formulation development, manufacturing controls, finished-product testing and stability evaluation.
Sharing Formulations Pvt. Ltd. specializes in pharmaceutical mouthwash and liquid external preparation manufacturing in India, with established experience in Benzydamine HCl 0.15% Mouthwash and related oromucosal formulations.
